Littlejohn & Co. LLC Trims Holdings in Aveanna Healthcare Holdings Inc. $AVAH

Littlejohn & Co. LLC lessened its holdings in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) by 21.2% during the first quarter, Holdings Channel.com reports. The firm owned 2,203,362 shares of the company’s stock after selling 594,142 shares during the quarter. Aveanna Healthcare accounts for 13.4% of Littlejohn & Co. LLC’s investment portfolio, making the stock its 3rd largest holding. Littlejohn & Co. LLC’s holdings in Aveanna Healthcare were worth $14,190,000 as of its most recent SEC filing.

Several other hedge funds have also added to or reduced their stakes in AVAH. Dynamic Technology Lab Private Ltd boosted its position in Aveanna Healthcare by 8.9% during the third quarter. Dynamic Technology Lab Private Ltd now owns 14,149 shares of the company’s stock valued at $126,000 after buying an additional 1,151 shares during the period. Barclays PLC increased its holdings in shares of Aveanna Healthcare by 0.8% in the third quarter. Barclays PLC now owns 179,359 shares of the company’s stock worth $1,591,000 after buying an additional 1,366 shares during the period. Franklin Resources Inc. increased its holdings in shares of Aveanna Healthcare by 4.5% in the third quarter. Franklin Resources Inc. now owns 35,630 shares of the company’s stock worth $316,000 after buying an additional 1,528 shares during the period. Intech Investment Management LLC lifted its stake in shares of Aveanna Healthcare by 9.8% in the 4th quarter. Intech Investment Management LLC now owns 19,483 shares of the company’s stock valued at $159,000 after acquiring an additional 1,739 shares during the last quarter. Finally, Balboa Wealth Partners lifted its stake in shares of Aveanna Healthcare by 13.5% in the 4th quarter. Balboa Wealth Partners now owns 16,890 shares of the company’s stock valued at $138,000 after acquiring an additional 2,007 shares during the last quarter. 87.96% of the stock is owned by institutional investors.

Insiders Place Their Bets

In related news, major shareholder Paul R. Vigano sold 3,000,000 shares of the company’s stock in a transaction that occurred on Tuesday, June 30th. The stock was sold at an average price of $8.01, for a total transaction of $24,030,000.00. Following the completion of the transaction, the insider owned 190,130 shares in the company, valued at $1,522,941.30. This represents a 94.04% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, major shareholder J.H. Whitney Equity Partners V sold 2,419,035 shares of the firm’s stock in a transaction on Tuesday, June 30th. The stock was sold at an average price of $8.01, for a total value of $19,376,470.35. Following the completion of the sale, the insider directly owned 10,112,123 shares of the company’s stock, valued at $80,998,105.23. The trade was a 19.30% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders have sold 31,305,664 shares of company stock worth $215,555,910. Corporate insiders own 5.30% of the company’s stock.

Aveanna Healthcare Stock Performance

Aveanna Healthcare stock opened at $9.08 on Friday. The company has a current ratio of 1.47, a quick ratio of 1.47 and a debt-to-equity ratio of 5.35. The firm has a 50-day moving average of $8.16 and a 200-day moving average of $7.66. The firm has a market cap of $1.98 billion, a P/E ratio of 7.69, a P/E/G ratio of 0.94 and a beta of 1.89. Aveanna Healthcare Holdings Inc. has a 1-year low of $3.73 and a 1-year high of $10.32.

Aveanna Healthcare (NASDAQ:AVAH) last posted its earnings results on Thursday, May 14th. The company reported $0.18 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.13 by $0.05. Aveanna Healthcare had a return on equity of 124.68% and a net margin of 10.37%.The company had revenue of $647.91 million for the quarter, compared to analysts’ expectations of $613.22 million. The firm’s revenue was up 15.9% compared to the same quarter last year. Sell-side analysts expect that Aveanna Healthcare Holdings Inc. will post 0.68 EPS for the current year.

Analysts Set New Price Targets

AVAH has been the subject of several analyst reports. Barclays increased their target price on Aveanna Healthcare from $9.00 to $9.50 and gave the company an “overweight” rating in a report on Thursday, July 9th. Stephens upgraded Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and boosted their price objective for the company from $10.00 to $11.00 in a research report on Friday, May 15th. Truist Financial boosted their price objective on Aveanna Healthcare from $9.00 to $11.00 and gave the company a “hold” rating in a research report on Tuesday, July 14th. Weiss Ratings reissued a “hold (c+)” rating on shares of Aveanna Healthcare in a research note on Thursday, July 2nd. Finally, Royal Bank Of Canada upgraded shares of Aveanna Healthcare from a “sector perform” rating to an “outperform” rating and set a $10.00 target price on the stock in a report on Wednesday, June 3rd. One equities research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $10.78.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.